These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26602314)

  • 41. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 42. Needed: new and better tools to combat latent tuberculosis infection.
    Blumberg HM
    Ann Intern Med; 2008 Nov; 149(10):761-3. PubMed ID: 19017594
    [No Abstract]   [Full Text] [Related]  

  • 43. Isoniazid-induced bullous skin reaction.
    Scheid P; Kanny G; Tréchot P; Rosner V; Ménard O; Vignaud JM; Anthoine D; Martinet Y
    Allergy; 1999 Mar; 54(3):294-6. PubMed ID: 10321574
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of tuberculosis in elderly persons.
    Nagami P; Yoshikawa TT
    Compr Ther; 1984 Jul; 10(7):57-62. PubMed ID: 6540155
    [No Abstract]   [Full Text] [Related]  

  • 45. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koula-Shiro S
    Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambulatory management of tuberculosis.
    Hampton JR; Bates JH
    Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
    [No Abstract]   [Full Text] [Related]  

  • 47. An unusual recurrence of antitubercular drug induced hepatotoxicity in a child.
    Bhatia S; Tullu MS; Kannan S; Gogtay NJ; Thatte UM; Lahiri KR
    J Postgrad Med; 2011; 57(2):147-52. PubMed ID: 21654145
    [No Abstract]   [Full Text] [Related]  

  • 48. [Alopecia areata in a patient treated with antitubercular drugs].
    Tella E; Daubercies G; Sin C; Marchal A; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2014 Apr; 141(4):295-7. PubMed ID: 24703645
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].
    Costin M; Tesloianu A; Mihăescu T; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse effects of antituberculosis drugs.
    Girling DJ
    Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920
    [No Abstract]   [Full Text] [Related]  

  • 51. [Rifapex, a new antituberculosis agent].
    Sokolova GB; Krasnov VA; Reĭkhrud TA; Tsybanev AA
    Antibiot Khimioter; 2009; 54(1-2):38-41. PubMed ID: 19499716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Any questions? How should a patient be managed who is being treated for sputum positive pulmonary tuberculosis and becomes jaundiced in the third week of chemotherapy?
    Campbell IA
    Tubercle; 1990 Jun; 71(2):149. PubMed ID: 2219468
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 54. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 55. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.
    Ena J; Valls V
    Clin Infect Dis; 2005 Mar; 40(5):670-6. PubMed ID: 15714411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Rifampin in initial treatment of pulmonary tuberculosis: a U.S. Public Health Service tuberculosis therapy trial.
    Israel HL
    Am Rev Respir Dis; 1974 Jul; 110(1):104. PubMed ID: 4834622
    [No Abstract]   [Full Text] [Related]  

  • 57. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical course and effectiveness of treatment of destructive pulmonary tuberculosis in adolescents].
    Firsova VA; Nadyrshina RSh; Melikova VM
    Probl Tuberk; 1986; (5):14-7. PubMed ID: 3737587
    [No Abstract]   [Full Text] [Related]  

  • 59. Pulmonary tuberculosis initial treatment.
    N Z Med J; 1978 May; 87(611):321-2. PubMed ID: 276705
    [No Abstract]   [Full Text] [Related]  

  • 60. A man with a blistering eruption and tuberculosis.
    Lee CH; Yuen MM; Chow WS; Tso AW; Yeung CK; Chan JC; Chau CH; Lam KS
    BMJ; 2012 Jan; 344():d8351. PubMed ID: 22228698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.